Literature DB >> 23371025

Assessment of the significance of respiratory culture of Aspergillus in the non-neutropenic patient. A critique of published diagnostic criteria.

R C Barton1, R P Hobson, H McLoughlin, A Morris, B Datta.   

Abstract

Assessment of the significance of isolation of Aspergillus sp. from respiratory culture in patients who are not neutropenic is a continuing problem in respiratory medicine. In recent years a number of criteria for defining patients with invasive or chronic pulmonary aspergillosis in this group have been proposed. This study sought to assess the value of three sets of these criteria in distinguishing between colonisation and aspergillosis requiring therapy when applied retrospectively to 121 patients with positive sputum or BAL culture for Aspergillus sp. Two patients (1.6%) were identified as having proven or probable aspergillosis by the EORTC criteria, two different patients fulfilled the criteria for invasive aspergillosis in the 62 patients with chronic obstructive pulmonary disease (3.2%), and yet another two different patients met the criteria for chronic pulmonary aspergillosis (1.6%). It is suggested that difficulties in the application of some of these criteria may prevent the accurate diagnosis of aspergillosis in the non-neutropenic patient setting.

Entities:  

Mesh:

Year:  2013        PMID: 23371025     DOI: 10.1007/s10096-013-1827-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone.

Authors:  B A Leav; B Fanburg; S Hadley
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

Review 2.  Allergic bronchopulmonary aspergillosis.

Authors:  Paul A Greenberger
Journal:  J Allergy Clin Immunol       Date:  2002-11       Impact factor: 10.793

3.  Coexistence of allergic bronchopulmonary aspergillosis and active pulmonary tuberculosis.

Authors:  Kyung Hoon Min; Seoung Ju Park; So Ri Kim; Min Hee Lee; Chi Ryang Chung; Hyo Jin Han; Kyoung Hwa Choi; Myoung Ja Chung; Yong Chul Lee; Gong Yong Jin; Min Ho Kim
Journal:  Am J Respir Crit Care Med       Date:  2011-01-01       Impact factor: 21.405

4.  Aspergillus bronchitis without significant immunocompromise.

Authors:  Ales Chrdle; Sahlawati Mustakim; Rowland J Bright-Thomas; Caroline G Baxter; Timothy Felton; David W Denning
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

5.  A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility.

Authors:  K L Mortensen; H K Johansen; K Fuursted; J D Knudsen; B Gahrn-Hansen; R H Jensen; S J Howard; M C Arendrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-04       Impact factor: 3.267

6.  Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital.

Authors:  E Bouza; J Guinea; T Peláez; J Pérez-Molina; L Alcalá; P Muñoz
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

7.  Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests.

Authors:  Xiaofang Gao; Liangan Chen; Guangrong Hu; Haiyu Mei
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

8.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 9.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease.

Authors:  P Bulpa; A Dive; Y Sibille
Journal:  Eur Respir J       Date:  2007-10       Impact factor: 16.671

10.  Clinical features of invasive bronchial-pulmonary aspergillosis in critically ill patients with chronic obstructive respiratory diseases: a prospective study.

Authors:  Hangyong He; Lin Ding; Fang Li; Qingyuan Zhan
Journal:  Crit Care       Date:  2011-01-06       Impact factor: 9.097

View more
  2 in total

1.  Treatment of chronic pulmonary aspergillosis with voriconazole: review of a case series.

Authors:  G Cucchetto; A Cazzadori; M Conti; G L Cascio; P Braggio; E Concia
Journal:  Infection       Date:  2014-11-29       Impact factor: 3.553

2.  Pulmonary Metagenomic Sequencing Suggests Missed Infections in Immunocompromised Children.

Authors:  Matt S Zinter; Christopher C Dvorak; Madeline Y Mayday; Kensho Iwanaga; Ngoc P Ly; Meghan E McGarry; Gwynne D Church; Lauren E Faricy; Courtney M Rowan; Janet R Hume; Marie E Steiner; Emily D Crawford; Charles Langelier; Katrina Kalantar; Eric D Chow; Steve Miller; Kristen Shimano; Alexis Melton; Gregory A Yanik; Anil Sapru; Joseph L DeRisi
Journal:  Clin Infect Dis       Date:  2019-05-17       Impact factor: 9.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.